Friday 6 November 2026 Export ADPT’s income statement to Excel — free account

Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation’s revenue for fiscal 2025 (year ended December 2025) was $277.0 million, up 54.8% from fiscal 2024.

Revenue: −10.7%
EPS: −66.7%
Free cash flow: +201.9%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

27.26 0.43 +1.60%

Follow ADPT

Alert me

Market cap: $4.3B
P/E: 0.0×
Fwd P/E: −49.4×
Dividend yield: —
F-score: 6/9
Altman Z: 2.08
Beneish M: −2.44
Dividend safety: n/a

Overview

Adaptive Biotechnologies Corporation (ADPT) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Adaptive Biotechnologies Corporation (ADPT) trades at a P/B ratio of 23.5×. Over the past ten years it has ranged from 0.0× (September 2019) to 31.4× (September 2026); the current reading is higher than 97% of that period. That is above the Diagnostics & Research industry median of 3.4× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ADPT/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Adaptive Biotechnologies Corporation P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ADPT/metrics/pb-ratio">Adaptive Biotechnologies Corporation (ADPT) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	11.0×	151.23%
FY2024	4.4×	95.12%
FY2023	2.2×	(6.73%)
FY2022	2.4×	(63.26%)
FY2021	6.5×	(37.55%)
FY2020	10.4×	188.05%
FY2019	3.6×	—
FY2018	0.0×	—
FY2017	0.0×	—

Period	P/B ratio	Change
Sep 2026	25.2×	10.76%
Jun 2026	22.8×	136.42%
Mar 2026	9.6×	(12.09%)
Dec 2025	11.0×	(1.91%)
29 more quarters	Free account

Against its own ten years

Low 0.0× High 31.4×

Ten-year median 5.7×

Current reading's percentile 97

Company	P/B ratio
VCYT Veracyte, Inc. compare	1.4×
GRAL GRAIL, Inc. compare	2.4×
NEO NeoGenomics, Inc. compare	2.7×
RDNT RadNet, Inc. compare	4.4×
SHC Sotera Health Company compare	6.2×
WGS GeneDx Holdings Corp. compare	7.9×
CDNA CareDx, Inc. compare	8.6×
BLLN BillionToOne, Inc. compare	9.9×
ADPT Adaptive Biotechnologies Corporation	23.5×
Diagnostics & Research industry median	3.4×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Adaptive Biotechnologies Corporation (ADPT) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on ADPT

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on ADPT

Stockrow Weekly